v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Stockholder’s Equity - USD ($)
$ in Thousands
Series A
Preferred stock
Series B
Preferred stock
Series C
Preferred stock
Common stock
Additional paid-in capital
Non-controlling interest
Accumulated deficit
Total
Balance at Dec. 31, 2024 $ 7,435   $ 21,022   $ (33,571) $ (5,114)
Balance (in Shares) at Dec. 31, 2024 6,000 107   380        
Net loss     (1,700) (1,700)
Shares issued for services   88   88
Shares issued for services (in Shares) 14,000     9        
Common stock issued for cash   95   95
Common stock issued for cash (in Shares)       470        
Prefunded warrants issued for cash   395   395
Series B (cashless warrants)   14,710   14,710
Series B (cashless warrants) (in Shares)            
Expenses relating to funding   (1,524)   (1,524)
Conversion of debt to equity   1,191   1,191
Conversion of debt to equity (in Shares)     176        
Shares issued for acquisition (Contingent Consideration)     400   400
Shares issued for acquisition (Contingent Consideration) (in Shares)       40        
Issue of Options (ISO/NSO)   36   36
Balance at Mar. 31, 2025 $ 7,435   36,413   (35,271) 8,577
Balance (in Shares) at Mar. 31, 2025 20,000 107   1,075        
Balance at Dec. 31, 2025 $ 7,435 $ 11 45,534 $ (37) (42,999) 9,944
Balance (in Shares) at Dec. 31, 2025 20,000 107   142,426        
Net loss (24) (6,174) (6,198)
Effects of exchange translation reserve (OCI) (166) (166)
Common stock and pre-funded warrants issued for acquisition 12,000 12,000
Common stock and pre-funded warrants issued for acquisition (in Shares) [1]       55,682        
Preferred stock to be issued for acquisition 18,000 18,000
Common stock issued for cash 5,387 5,387
Common stock issued for cash (in Shares)   515,326        
Conversion of debt to equity 10,167 10,167
Conversion of debt to equity (in Shares)   451,437        
Equity issued pursuant to a financing arrangement 3,563 3,563
Equity issued pursuant to a financing arrangement (in Shares)       681,553        
Balance at Mar. 31, 2026 $ 7,435 $ 18,000 $ 11 $ 76,651 $ (61) $ (49,339) $ 52,697
Balance (in Shares) at Mar. 31, 2026 20,000 107   1,846,424        
[1] See note 5(B) for details on common stock and pre-funded warrants issued in connection with the acquisition.